1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
RFA documents for 2027 cycle are listed but specific deadline dates are not visible on the page.
New Jersey Prostate Cancer Research Fund is sponsored by New Jersey Department of Health / New Jersey Commission on Cancer Research (NJCCR). The New Jersey Prostate Cancer Research Fund supports innovative research focusing on the causes, prevention, screening, treatment, and cure of prostate cancer. This includes basic, behavioral, clinical, demographic, epidemiological, and psychosocial research.
Get alerted about grants like this
Get emailed when new opportunities from “New Jersey Department of Health / New Jersey Commission on Cancer Research (NJCCR)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Qualified research institutions in New Jersey, including academic medical institutions, state or local government agencies, and public or private organizations. Confirm the full requirements in the official notice before applying.
New Jersey Prostate Cancer Research Fund is funded by New Jersey Department of Health / New Jersey Commission on Cancer Research (NJCCR). Verify program details on the funder's official page before applying.
This opportunity targets applicants in New Jersey. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
RWJF's Health Equity Research for Action puts up ~20 grants of up to $500,000 — but demands a two-year community partnership and a community co-PI. Here's the strategy, set against the brightest foundation-giving outlook since 2022.
Read articleCMS awarded all 50 states a slice of the $50 billion Rural Health Transformation Program on December 29, 2025 — first-year checks average $200M, ranging from $147M to $281M. The federal application is closed and you cannot apply to CMS. The money reaches hospitals, clinics, and nonprofits only as state subawards, and those competitions open through 2026. Here is how the formula worked, what the funds can and cannot buy, and how to position for a subaward before the money starts flowing.
Read articleCMS awarded the entire $50 billion Rural Health Transformation Program to all 50 states, with first-year checks averaging $200M per state and money starting to move October 1, 2026. The federal contest is over — but for rural hospitals, clinics, behavioral-health providers, and nonprofits, the real competition is just beginning inside each state's sub-grant process. Here is how the money splits, what it can fund, and how to position now.
Read article